Health economic analyses of psoriasis management: a systematic literature search

Estimated cost efficacy of systemic treatments that are approved by the US Food and Drug Administration for the treatment of moderate to severe psoriasis

(2015) Logan S. D'Souza et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

The impact of biologic therapy in chronic plaque psoriasis from a societal perspective: an analysis based on Italian actual clinical practice

(2015) B. Polistena et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

The Cost Effectiveness of Biologic Therapy for the Treatment of Chronic Plaque Psoriasis in Real Practice Settings in Italy

(2014) Federico Spandonaro et al.   BIODRUGS

Cost-efficacy of biologic therapies for moderate to severe psoriasis from the perspective of the Taiwanese healthcare system

(2014) Shu-Hui Wang et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

Biological Therapies for the Treatment of Severe Psoriasis in Patients with Previous Exposure to Biological Therapy: A Cost-Effectiveness Analysis

(2014) Laura M. Sawyer et al.   PHARMACOECONOMICS

Efficacy and Cost-Efficacy of Biologic Therapies for Moderate to Severe Psoriasis: A Meta-Analysis and Cost-Efficacy Analysis Using the Intention-to-Treat Principle

(2014) Ching-Chi Chi et al.   Biomed Research International

Cost Effectiveness of Biologic Therapies for Plaque Psoriasis

(2013) Christine S. Ahn et al.   AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

Topical therapies for the treatment of localized plaque psoriasis in primary care: a cost-effectiveness analysis

(2013) L. Sawyer et al.   BRITISH JOURNAL OF DERMATOLOGY

Comparison of clinical and cost-effectiveness of psoralen + ultraviolet A versus psoralen + sunlight in the treatment of chronic plaque psoriasis in a developing economy

(2013) Komal Aggarwal et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

Cost Effectiveness of Moderate to Severe Psoriasis Therapy with Etanercept and Ustekinumab in the United States

(2013) Reginald Villacorta et al.   PHARMACOECONOMICS

Cost Per Responder Associated with Biologic Therapies for Crohn’s Disease, Psoriasis, and Rheumatoid Arthritis

(2012) Yifei Liu et al.   ADVANCES IN THERAPY

S3 - Guidelines on the treatment of psoriasis vulgaris (English version). Update

(2012) Alexander Nast et al.   JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT

Cost-efficacy comparison of biological therapies for patients with moderate to severe psoriasis in Japan

(2012) Atsuyuki Igarashi et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Topical vitamin D analogues alone or in association with topical steroids for psoriasis: a systematic review

(2012) S Devaux et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Positive Effect of Modified Goeckerman Regimen on Quality of Life and Psychosocial Distress in Moderate and Severe Psoriasis

(2011) JC Ho et al.   ACTA DERMATO-VENEREOLOGICA

A pharmacoeconomic analysis of severe psoriasis therapy: a review of treatment choices and cost efficiency

(2011) Jonathan P Staidle et al.   EXPERT OPINION ON PHARMACOTHERAPY

Cost per responder analysis of ustekinumab and etanercept for moderate to severe plaque psoriasis

(2011) Silas Martin et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Cost-efficacy of adalimumab, etanercept, infliximab and ustekinumab for moderate-to-severe plaque psoriasis

(2011) C. Ferrándiz et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Cost-effectiveness evaluation of clobetasol propionate shampoo (CPS) maintenance in patients with moderate scalp psoriasis: a Pan-European analysis

(2011) K. Papp et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Cost Utility Analysis Based on a Head-to-Head Phase 3 Trial Comparing Ustekinumab and Etanercept in Patients with Moderate-to-Severe Plaque Psoriasis: A Canadian Perspective

(2011) Feng Pan et al.   VALUE IN HEALTH

Cost effectiveness of the two-compound formulation calcipotriol and betamethasone dipropionate gel in the treatment of scalp psoriasis in Scotland

(2010) Andrew G. Affleck et al.   CURRENT MEDICAL RESEARCH AND OPINION

A psoriasis-specific model to support decision making in practice – UK experience

(2010) Keith Freeman et al.   CURRENT MEDICAL RESEARCH AND OPINION

Cost-effectiveness analysis of TNF-α blockers for the treatment of chronic plaque psoriasis in the perspective of the Italian health-care system

(2010) Simona de Portu et al.   Dermatologic Therapy

Cost-Effectiveness of Biological Therapy in Remission Induction of Moderate to Severe Plaque Psoriasis

(2010) K. Schmitt-Rau et al.   DERMATOLOGY

Economic evaluation of biologic therapies for the treatment of moderate to severe psoriasis in the United States

(2010) Aslam H. Anis et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Economic evaluation of etanercept in the management of chronic plaque psoriasis

(2008) A. Lloyd et al.   BRITISH JOURNAL OF DERMATOLOGY

Economic evaluation of systemic therapies for moderate to severe psoriasis

(2008) S. Sizto et al.   BRITISH JOURNAL OF DERMATOLOGY

Economic considerations in psoriasis management

(2008) Marc Alexander Radtke et al.   CLINICS IN DERMATOLOGY

The impact of psoriasis on health care costs and patient work loss

(2008) Joseph F. Fowler et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

German Recommendations on Health Economic Evaluation: Third and Updated Version of the Hanover Consensus

(2008) J.-Matthias Graf von der Schulenburg et al.   VALUE IN HEALTH

Cost-effectiveness of biologic treatments for psoriasis based on subjective and objective efficacy measures assessed over a 12-week treatment period

(2007) Andrew A. Nelson et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY